金牛座7号诱导的过敏反应:一个儿科病例报告
Elise Mank1, Nancy Broos2, Ingrid Terreehorst3
1Department of Pediatrics, Emma Children's Hospital, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
Pediatric allergy, immunology, and pulmonology
|September 11, 2025
概括
塔罗塞普特 (TauroSept®) 是一种塔罗利丁锁溶液,对于接受肠道营养的儿童来说通常是安全的. 然而,这一案例突出了婴儿过敏症的罕见情况,强调了对潜在副作用的临床意识的必要性.
科学领域:
- 儿科胃肠病学 儿科胃肠病学
- 临床药理学 临床药理学
背景情况:
- 患有肠道衰竭的儿童需要通过中央静脉导管进行肠道营养,从而增加了与导管相关的血液感染的风险.
- 陶罗利丁锁定溶液已被广泛用于预防这些感染,并且在儿科患者中通常被认为是安全的.
研究的目的:
- 报告TauroSept® (taurolidine) 后婴儿出现过敏反应的第一个记录的病例.
主要方法:
- 一个病例报告详细介绍了一个1个月大的婴儿,患有状缩,接受肠道营养.
- 在TauroSept®注射后不久观察不良事件,包括循环不良和血管.
- 测量血清三酶水平以评估过敏反应.
主要成果:
- 在TauroSept®注射后,婴儿出现了与过敏反应一致的严重症状.
- 血清三酶水平显著增加,证实了过敏反应.
- 这一事件表明婴儿对塔罗利丁的罕见但严重的不良反应.
结论:
- 这一案例是全球范围内首次报告婴儿对TauroSept®的过敏反应.
- 医疗保健提供者应该保持意识到这种潜在的,虽然很少见的副作用,当使用taurolidine锁定解决方案在儿科患者.
相关概念视频
Allergic Reactions
31.9K
Overview
31.9K
Allergic Drug Reactions
1.3K
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.3K
Desensitization and Tachyphylaxis
2.9K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
2.9K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
219
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
219
Teratogenicity
3.9K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.9K
Pharmacokinetics in Pediatric Patients: Drug Metabolism
165
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
165


